2FINBERG K E, SEQUIST L V, JOSHI V A, et al. Mucin ous differentiation correlates with absence of KRAS mutation in lung adenocarinomas with bronchioloalveolar features[J]. Journal of Mo|ecular Diagnostics, 2007, 9(3): 320-326.
3WISLEZ M, ANTOINE M, BAUDRIN L, et al. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib[J]. Lung cancer, 2010, 65(2): 185-191.
5GRIFFITHS D J, MARTINEAU H M, COUSENS C, et al. Pathology and pathogenesis of ovine pulmonary adenocarcinoma[J]. J Comp pathol, 2010, 142(4): 260-283.
7ANDRE L. Bronchionloalveolar carcinoma and minimally invasive adenocarcinoma[J]. Surgical Pathology, 2010, 3(1): 1-26.
8TRAVIS W D, GARG K, FRANKLIN M A, et al. Bronchioloalvrolar carcinoma and lung adenocarcinoma:the clinical important and research relevance of the 2004 World Health Orzanization oatholozic criteriaH1. I Thorac Oncol. 2006. 1 (9 Sunole): S 13-S 19.
4Hunninghake GW, Zimmerman M B, Schwartz D A, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med ,2001,164 ( 1 ) : 193.
5Read WL, Page NC, Tierney RM, et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades:analysis of the SEER database [ J ]. Lung Cancer, 2004,45 ( 2 ) : 137 - 142.
6Tao LC, Weisbrod GL, Pearson FG, et al. Cytologic diagnosis of bronchioloalveolar carcinoma by fine-needle aspiration biopsy[ J]. Cancer, 1986,57(8 ) : 1565 - 1570.
7Hasegawa M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography [ J ]. Ann Thorac Surg, 2003,75 (5) : 1601 - 1606.
8Jackman DM,Cbirieac LR,Janne PA.Bronchioloalveolar carcinoma:a review of the epidemiology,pathology and treatment[J].Semin Respir Crit Care Med,2005,26(3):342-352.
9Travis WD,Garg K,Franklin MA,et al.Bronchioloalveolar carcinoma and lung adenocarcinoma:the clinical important and research relevance of the 2004 World Health Organization pathologic criteria[J].J Thorac Oncol,2006,1(9 Suppl):S13-S19.
10Jackman DM,Chirieac LP,Janne PA.Bronchioloalveolar carcinoma:a review of the epidemiology,pathology and treatment[J].Semin Respir Crit Care Med,2005,26(3):342-352.
1Bourke S J, Dalphin J C, Boyd G, et al. Hypersensitivity pneumonitis: current concepts [ J ]. Eur Respir J Suppl, 2001,32(18) :81-92.
2Martinez F J, Keane M P. Update in diffuse parenchymal lung diseases 2005 [ J]. Am J Respir Crit Care Med, 2006,173 (10) : 1066-1071.
3Bogaert P, Tournoy K G, Naessens T, et al. Where asth- ma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma [ J ]. Am J Pathol, 2009, 174(1) :3-13.
4Coleman A, Colby T V. Histologic diagnosis of extrinsic allergic alveolitis[J]. Am J Surg Pathol, 1988,12 (7) : 514-518.
5Bah'era L, Mendoza F, Zuniga J, et al. Functional diver- sity of T-cell subpopulations in subacute and chronic hy- persensitivity pneumonitis [ J ], Am J Respir Crit Care Med, 2008,177(1) :44-55.
